- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Page 465
1mg seeks $35m dose of funding
The Intel Capital-backed pharmaceutical e-commerce platform has begun raising a new funding round that would reportedly value the company at $200m.
Jan 11, 2019Foxconn's McCabe joins Future Family
Jen McCabe, an ex-business development director at Flex who was most recently an investment director at Foxconn, will head business development for Future Family.
Jan 11, 2019IU fund pours $500,000 into Diagnotes
Indiana University Philanthropic Venture Fund has joined Purdue Ventures and university-backed VC vehicle Indiana Seed Fund as an investor in healthcare communication platform Diagnotes.
Jan 10, 2019Washington likes the look of Neoleukin
Immunooncology spinout Neoleukin Therapeutics is working on a safer, synthetic replica of a T-cell-boosting protein called interleukin-2.
Jan 10, 201910x enlarges series D to $85m
Genomics tool developer 10x Genomics has raised $35m that will be combined with the $50m SoftBank-backed first close it achieved in April.
Jan 10, 2019Hill-Rom sees EarlySense in $39m round
Hill-Rom and Wells Fargo have co-led the medical monitoring device maker's latest round, taking its total funding to almost $140m.
Jan 10, 2019PetaGene generates $2.1m
PetaGene hopes its data compression technology will aid the genomic sequencing industry.
Jan 9, 2019NUI Galway companies garner $40m in 2018
NUI Galway-linked businesses to have secured backing last year include kidney reflux test spinout Kite Medical and medical implant developer Loci Orthopaedics.
Jan 9, 2019Alector selects Nasdaq for $150m IPO
MRL Ventures, GV, AbbVie Ventures, Lilly Asia Ventures and Amgen Ventures are all in line to exit the immuno-neurology drug developer.
Jan 9, 2019Providence Ventures produces $150m second fund
The Providence St Joseph Health-managed corporate venturing unit has doubled its capital reserves to $300m by launching a second fund.
Jan 9, 2019About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


